Clinical trials

  • avapritinib for Indolent systemic mastocytosis | Systemic mastocytosis
  • RITUXIMAB for ANCA-associated vasculitis | End-stage renal disease
  • SAVOLITINIB for Non-small cell lung cancer (EGFR-mutant, MET-amplified/overexpressed)
  • BEVACIZUMAB for High-grade glioma|Brain metastases
  • EMPAGLIFLOZIN for Chronic kidney disease
  • 18F-fluoroestradiol for Breast cancer | Luminal A breast cancer | ER-positive lobular breast cancer
  • CETRELIMAB for Muscle-invasive bladder cancer (MIBC) | Bladder cancer
  • GUSELKUMAB for Psoriatic arthritis
  • IODIXANOL for Female infertility
  • MTX46943 for Alzheimer's disease
  • SAVOLITINIB for Non-small cell lung cancer | EGFR-mutant non-small cell lung cancer | MET-amplified/overexpressed non-small cell lung cancer
  • LUXDEGALUTAMIDE for Metastatic castration-resistant prostate cancer (mCRPC)